by Robert Hayes Posted on April 18, 2024April 18, 2024 PETA Alleges Wilmington’s Charles River Labs Misled Shareholders On Sourcing Of Monkeys, Urges SEC To Investigate Read More
by Robert Hayes Posted on April 16, 2024April 17, 2024 BUSINESS BRIEF: Wilmington’s Charles River Laboratories Launches Alternative Methods Advancement Project To Reduce Reliance on Animal Testing Read More
by Robert Hayes Posted on April 9, 2024April 10, 2024 BUSINESS BRIEF: Wilmington’s Charles River Announces Rare Disease Gene Therapy Collaboration with Axovia Therapeutics Read More
by Robert Hayes Posted on April 5, 2024April 5, 2024 BUSINESS BRIEF: Wilmington’s Charles River & Navega Therapeutics Announce Comprehensive Gene Therapy Manufacturing Collaboration Read More
by Robert Hayes Posted on January 29, 2024January 29, 2024 BUSINESS BRIEF: Wilmington’s Charles River Laboratories Adds Reshema Kemps-Polanco To Board Of Directors Read More
by Robert Hayes Posted on July 26, 2023July 26, 2023 OBITUARY: Kathleen A. Murray, D.V.M, 68 Read More
by Robert Hayes Posted on May 30, 2023May 30, 2023 Wilmington’s Charles Rivers Labs Receives $1.47 Million In Job Creation Incentives From State, Will Create 98 New Jobs Read More
by Robert Hayes Posted on April 29, 2023April 29, 2023 Wilmington’s Charles River Labs Named A Top Ten Massachusetts Company For Gender Equity Among Executive Leadership Read More
by Robert Hayes Posted on February 23, 2023February 23, 2023 Wilmington’s Charles River Labs Under Federal Investigation Related To Importation Of Monkeys From Cambodia Read More
You must be logged in to post a comment.